A recent study has shed light on a unique subset of amyloid beta proteins, referred to as “superspreaders,” that seem to spread throughout brain tissue more rapidly in Alzheimer’s disease. By observing amyloid beta proteins under an atomic force microscope in a salt solution mimicking brain conditions, researchers found that some amyloid beta proteins, specifically amyloid beta 42, adopt highly reactive structures that accelerate clump formation. This unique behavior could explain the rapid increase of amyloid plaques as the disease progresses. Led by molecular physicist Peter Nirmalraj and conducted at EMPA in collaboration with the University of Limerick, the study emphasizes that while amyloid plaques have long been associated with Alzheimer’s, their exact role remains unclear. These findings represent a significant step in understanding the biochemical environment that drives amyloid spread, potentially pointing towards new, more effective treatments targeting these superspreader proteins.
Home » Superspreading Proteins Unveiled: A Breakthrough in Alzheimer’s Disease Progression
Superspreading Proteins Unveiled: A Breakthrough in Alzheimer’s Disease Progression
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Fasting Mimetic Supplement Shows Cardioprotective Promise
November 30, 2024
Breaking the Code: Enzyme TYK2 Offers Hope for Alzheimer’s Treatment
November 30, 2024
Sucrosomial® B12: A Breakthrough in B12 Supplementation
November 30, 2024
Harnessing Beneficial Bacteria: A Breakthrough in UTI Management
November 25, 2024
Activ’Inside’s Belight: A Natural Solution for Skin Hyperpigmentation
November 22, 2024